Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa

NCT00869791 is registered in ClinicalTrials.gov with Impax Laboratories, LLC as lead sponsor.

NCT NCT00869791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00869791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
Lead sponsor
Impax Laboratories, LLC
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
June 30, 2009
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease